Skip to content

Guardant Health GH Market capitalization

Market capitalization at other companies

Illumina logo
IlluminaILMN
$18.85B+50.0%
Natera, Inc. logo
Natera, Inc.NTRA
$28.34B+48.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$21.53B+14.7%
Agilent Technologies logo
Agilent TechnologiesA
$32.65B+7.0%
Labcorp Holdings logo
Labcorp HoldingsLH
$21.99B+12.9%
Abbott logo
AbbottABT
$178.41B-22.5%

Other financials

Income statement

See full
Revenue$301.7M+48.3%
Gross profit$196.7M+52.8%
Operating income-$121.4M-9.3%
Net income-$112.1M-17.8%
EPS (diluted)-$0.85-10.4%

Balance sheet

See full
Cash & equivalents$1.1B+37.0%
Total debt$1.7B+30.5%
Total equity-$181.1M+27.8%
Total assets$1.9B+42.5%

Cash flow

See full
Operating cash flow-$65.6M-4.7%
CapEx$5.6M+25.1%
Free cash flow-$71.2M-6.0%

Valuation

See full
Enterprise value$17.72B+121%
P/S15.9×+6.3×

Profitability

See full
Gross margin64.9%+3.6pp
Operating margin-41.4%-9.4pp
Net margin-40.1%-8.1pp

Returns & leverage

See full
Return on equity-438.1%-1,655pp
Debt / equity
Current ratio4.7×+0.6×

Where this comes from

Computed from the period-end share price: $12.12B.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardant Health's market capitalization?
Guardant Health (GH) reported market capitalization of $12.12B in Q1 2026.
How has Guardant Health's market capitalization changed year-over-year?
Guardant Health's market capitalization increased by 130.4% year-over-year, from $5.26B to $12.12B.
What is the long-term trend for Guardant Health's market capitalization?
Over 4 years (2021 to 2025), Guardant Health's market capitalization has grown at a -10.7% compound annual growth rate (CAGR), from $51.02B to $32.51B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.